Medicine Overview of Nebycare H 5mg/12.5mg Tablet
Nebycare H 5mg/12.5mg Tablet is used in the treatment of hypertension
Nausea, Constipation, Diarrhoea, Fatigue, Dizziness, Headache, Increased blood uric acid, Decreased potassium level in blood, Glucose intolerance, Altered blood lipids, Shortness of breath, Swelling of hands, Swelling of feet, Paresthesia (tingling or pricking sensation), Decreased magnesium level in blood, Increased calcium level in blood.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Nebycare H 5mg/12.5mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Nebycare H 5mg/12.5mg Tablet is a combination of two medicines: Nebivolol and hydrochlorothiazide that help control your blood pressure. Nebivolol is a beta blocker that lowers your heart rate. Indapamide is a diuretic that removes extra water and certain electrolytes from your body. This also reduces the risk of a heart attack or stroke.
In Depth Information on Nebycare H 5mg/12.5mg Tablet
Taking Hydrochlorothiazide with alcohol may have additive ef
fects in lowering blood pressure. You may experience headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate.
WEIGH RISKS VS BENEFITS
Nebycare H 5mg/12.5mg Tablet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Nebycare H 5mg/12.5mg Tablet is probably unsafe to use durin
Limited human data suggest that the drug could represent a significant risk to the baby.
Nebycare H 5mg/12.5mg Tablet may make you feel dizzy, sleepy
, tired, or decrease alertness. If this happens, do not drive.
Nebycare H 5mg/12.5mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Nebycare H 5mg/12.5mg Tablet may be needed. Please consult your doctor.
Use of Nebycare H 5mg/12.5mg Tablet is not recommended in patients with severe kidney disease.
Nebycare H 5mg/12.5mg Tablet should be used with caution in
patients with liver disease. Dose adjustment of Nebycare H 5mg/12.5mg Tablet may be needed. Please consult your doctor.
No Patient Concerns found for this medicine
One of the following vendor pharmacies will deliver Nebycare H 5mg/12.5mg Tablet: RKS, DLP, DDR, SJP, OWP, MAK, SVH, SAF, MPC, FGH, PTI, BIO, WLC, HIP, SHP, ATL, STA, RHW, 9T9, TRP, NVL, SBL, MSD, SWA, EQN, INC, DPP, PEN, AGT, SSA, ZVP, AVN, LCC, NVY, BMJ, BTM, DPL, BSN, GNC, SAT, NWP, AAY, SHM, ENP, SDM, HMP, NNH, RUS, UMP, LHA, MLC, MMS, RSS, GBL, PNT, NDP, KHH, GPT, JIV, IAD, ATP, HAT, DYG, NSL, JVN, AMR, HEX, DFP, RJH, OIP, GTK, RSA, HRV, SBA, BBS, JMJ, RPP, OLT, GTC, IPL, PPR, USF, HGI, JVO, MAM, AYU, CLT, BDN, MOM, WSI, ARD, HBV, DHR, PLT, MAX, OHM, AAR, EMB, ADT, PVP